[Retracted] Cell Proliferation and Tumor Induction by Ochratoxin A in Mouse Skin and Evaluation of Cyclin D1 and Cyclooxygenase-2 Expressions

Table 1

Experimental design with dosing details.

S. no.	Group number	Description
1.	Group I	Control group (0.2 ml acetone; 2 times weekly administration)
2.	Group II	DMBA administered topically (120 nmol/0.2 ml acetone); then TPA (4 nmol/0.2 ml of acetone) applied 2 times weekly post 1-week initiation
3.	Group III	DMBA administered topically (120 nmol/0.2 ml acetone); OTA (25 nmol/0.2 ml acetone) applied 2 times weekly post 1-week initiation
4.	Group IV	DMBA administered topically (120 nmol/0.2 ml acetone); OTA (50 nmol/0.2 ml acetone) applied 2 times weekly post 1-week initiation
5.	Group V	Acetone administered topically (0.2 ml/mouse); OTA (25 nmol/0.2 ml acetone) applied 2 times weekly post 1-week initiation
6.	Group VI	Acetone administered topically (0.2 ml/mouse); OTA (50 nmol/0.2 ml acetone) applied 2 times weekly post 1-week initiation